MedPath

Clinical study on improving ovarian function of women with perimenopausal syndrome by Zishui Qinggan Lichong Decoctio

Phase 1
Conditions
Perimenopausal syndrome
Registration Number
ITMCTR2000002899
Lead Sponsor
The Third Affiliated Hospital of Beijing University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

1. Those who have symptoms of perimenopausal syndrome and meet the diagnostic criteria of traditional Chinese and western medicine and syndrome differentiation criteria of kidney deficiency and liver stagnation of perimenopausal syndrome;
2. 20IU/L <= SH <= 40IU/L;
3. Have not used any sex hormone in the last 3 months or any drug that has an effect on sex hormone level in the last 2 months;
4. Denied allergy to traditional Chinese medicine;
5. Aged 40-55 years.

Exclusion Criteria

1. Patients with unexplained irregular vaginal bleeding, ovarian tumors, uterine fibroids >= 4cm, severe breast hyperplasia and breast tumors;
2. Patients with severe primary diseases, such as cardiovascular, lung, liver, kidney and hematopoietic system, are mentally ill;
3. Unable to insist or unwilling to cooperate with the treatment;
4. Incomplete data or unauthorized use of other treatments may affect the evaluation of efficacy.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum sex hormone;
Secondary Outcome Measures
NameTimeMethod
Kupperman score;Quality of life measurement (QOL-BREF);
Âİ Copyright 2025. All Rights Reserved by MedPath